Let’s partner!
Our KPIs are aligned with our partners’ objectives: acquisition, adherence, and health impact.
Improve margin and differentiate
Corporate health insurance margins are driven down by commoditisation and an increase in chronic disease costs. Differentiate your employer offerings while reducing the cost of claims thanks to Elfie.
Improve health, reduce premiums
50% of your employees don’t know they have a chronic disease. Give them the help they need to prevent and manage chronic conditions while lowering costs.
Acquisition with a social impact
With Elfie, brands access a hard-to-reach, highly-loyal demographic: Gen-X. By providing Elfie users with great rewards, you get both reach, acquisition, and social impact at no cost.
Adherence until the next visit
Less than 40% of patients are adherent. The International Society of Hypertension and the regional/national cardiology associations all recommend patients use mobile applications to increase adherence.
Learn about how digital solutions have delivered clinically measured health impact on blood pressure.
Patient loyalty, free of charge
HMOs and clinics want to drive patient loyalty to their care providers. Most quickly realized that building and maintaining successful patient mobile applications is a very costly and rare expertise.
Learn about how you can deploy Elfie to your patients at no cost to deliver on your patient objectives.
Patient acquisition and drug refills
Every month, Elfie users have to go to the pharmacy to get the same pills. Why not go to yours?
Most chronic disease patients stop their treatment within a year. Learn how Elfie is used as a loyalty solution by pharmacies across the world.
Grow the market, differentiated
For chronic disease drug manufacturers, the biggest competitor is patients’ lack of awareness and adherence. Elfie increases patients' lifetime value by focusing on both of these.
With the pressure of generics, Elfie also acts as a patient program to differentiate your approach to HCPs and demonstrate a beyond-the-pill impact to public payers.
